Perrigo | PRGO - Selling And Administration Expenses


Perrigo reported $271.7M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.84B 205M Sep/2026
Abbott USD 4.27B 669M Sep/2026
Bayer EUR 4.02B 53M Sep/2026
Bristol-Myers Squibb USD 1.7B 127M Sep/2026
Coherus Biosciences USD 15M 6.26M Dec/2025
Corcept Therapeutics USD 142.04M 14.86M Sep/2026
Dr.Reddys Laboratories INR 26.1B 11.63B Jun/2026
Eli Lilly USD 3.12B 305M Sep/2026
J&J USD 6.25B 168M Sep/2026
Merck USD 2.86B 25M Sep/2026
Nestle CHF 12.33B 133M Jun/2026
Pacira USD 950.8M 858.99M Sep/2026
Perrigo USD 271.7M 3.01B Sep/2026
Pfizer USD 3.28B 132M Sep/2026
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Prestige Brands USD 2.08B 2.04B Sep/2026
Sanofi EUR 2.31B 325M Sep/2026
Supernus Pharmaceuticals USD 133.64M 15.41M Jun/2026
Teva Pharmaceutical Industries USD 1.01B 27M Sep/2026
Xeris Pharmaceuticals USD 61.04M 7.89M Jun/2026
Zoetis USD 582M 10M Sep/2026